AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2014
Aug 4, 2014
31982_dirs_2014-08-04_5a31336a-d93e-4ceb-8990-81da487cf3b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2014-07-31
Reporting Person: Erck Stanley C (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-31 | Common Stock | P | 6788 | $2.28 | Acquired | 91656 | Direct |
Footnotes
F1: Includes 6,788 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on July 31, 2014.